Anal Cancer
What's New
Last Posted: Jul 07, 2023
- Estimating Risk of Locoregional Failure and Overall Survival in Anal Cancer Following Chemoradiation: A Machine Learning Approach.
Kevin A Chen et al. J Gastrointest Surg 2023 - Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Vendrely Véronique, et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2023 0 109542 - Anal HPV infection and correlates in HIV-infected patients attending a Sexually Transmitted Infection clinic in Brazil.
Tosato Boldrini Neide Aparecida, et al. PloS one 2018 0 (7) e0199058 - Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
Foster Corey C, et al. PloS one 2018 0 (3) e0194234 - Anal prevalence of HPV in women with pre-malignant lesion or cancer in the cervix and anal canal simultaneously: cross-sectional study.
Heráclio Sandra A, et al. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2019 0 (2) 225-232 - Human Papillomavirus Genotypes in Anal High-Grade Squamous Intraepithelial Lesion (HSIL): Anal Intraepithelial Neoplasia Grades 2 (AIN2) and 3 (AIN3) Are Different.
Roberts Jennifer M, et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2020 0 (10) 2078-2083 - Significance of HPV16 Viral Load Testing in Anal Cancer.
Ma?usecka Ewa, et al. Pathology oncology research : POR 2020 0 (4) 2191-2199 - Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV.
Lee Yu-Lin, et al. International journal of antimicrobial agents 2021 0 (3) 106403 - HPV genotypes detected by linear array and next-generation sequencing in anal samples from HIV positive men who have sex with men in Mexico.
González-Hernández Luz A, et al. Archives of virology 2018 0 (4) 925-935 - Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D, et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2022 0 233-238 - Identifying Predictors of Anal HPV Status in HPV-Vaccinated MSM: A Machine Learning Approach.
Ocagli Honoria et al. Journal of homosexuality 2022 1-17 - Artificial intelligence and high-resolution anoscopy: automatic identification of anal squamous cell carcinoma precursors using a convolutional neural network.
Saraiva M M et al. Techniques in coloproctology 2022 - Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - a proof-of-concept study.
Choudhury Ananya et al. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2021 - Development and Validation of a Natural Language Processing Algorithm for Surveillance of Cervical and Anal Cancer and Precancer: A Split-validation Study.
Oliveira Carlos R et al. JMIR medical informatics 2020 May - Cancer and Men
- Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.
Grinshpun Albert, et al. European journal of human genetics : EJHG 2018 1 - Low mutation percentage of KRAS and BRAF genes in Brazilian anal tumors.
Bidinotto Lucas Tadeu, et al. Molecular medicine reports 2016 10 (4) 3791-7 - KRAS and BRAF mutations in anal carcinoma.
Serup-Hansen Eva, et al. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2015 1 (1) 53-9 - KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
Casadei Gardini Andrea, et al. PloS one 2014 0 (3) e92071 - EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer.
Martin Vittoria, et al. Histology and histopathology 2014 4 (4) 513-21
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: